Literature DB >> 23797834

New developments in the diagnosis and treatment of thyroid cancer.

David F Schneider1, Herbert Chen.   

Abstract

Thyroid cancer exists in several forms. Differentiated thyroid cancers include those with papillary and follicular histologies. These tumors exist along a spectrum of differentiation, and their incidence continues to climb. A number of advances in the diagnosis and treatment of differentiated thyroid cancers now exist. These include molecular diagnostics and more advanced strategies for risk stratification. Medullary cancer arises from the parafollicular cells and not the follicular cells. Therefore, diagnosis and treatment differs from those of differentiated thyroid tumors. Genetic testing and newer adjuvant therapies have changed the diagnosis and treatment of medullary thyroid cancer. This review will focus on the epidemiology, diagnosis, workup, and treatment of both differentiated and medullary thyroid cancers, focusing specifically on newer developments in the field.
© 2013 American Cancer Society, Inc.

Entities:  

Keywords:  diagnosis; epidemiology; follicular thyroid cancer; medullary thyroid cancer; papillary thyroid cancer; thyroid cancer; treatment

Mesh:

Year:  2013        PMID: 23797834      PMCID: PMC3800231          DOI: 10.3322/caac.21195

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  212 in total

1.  Ultrasound-guided fine-needle aspiration biopsy of thyroid masses.

Authors:  C Carmeci; R B Jeffrey; I R McDougall; K W Nowels; R J Weigel
Journal:  Thyroid       Date:  1998-04       Impact factor: 6.568

Review 2.  Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma.

Authors:  Z W Baloch; V A LiVolsi
Journal:  Thyroid       Date:  2001-07       Impact factor: 6.568

3.  American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Authors:  Hossein Gharib; Enrico Papini; Roberto Valcavi; H Jack Baskin; Anna Crescenzi; Massimo E Dottorini; Daniel S Duick; Rinaldo Guglielmi; Carlos Robert Hamilton; Martha A Zeiger; Michele Zini
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

4.  The increasing incidence of small thyroid cancers: where are the cases coming from?

Authors:  Louise Davies; Michelle Ouellette; Mark Hunter; H Gilbert Welch
Journal:  Laryngoscope       Date:  2010-12       Impact factor: 3.325

Review 5.  The Chernobyl accident--an epidemiological perspective.

Authors:  E Cardis; M Hatch
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-05       Impact factor: 4.126

6.  Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies.

Authors:  Elena Bonora; Giovanni Tallini; Giovanni Romeo
Journal:  J Oncol       Date:  2010-06-10       Impact factor: 4.375

7.  Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid.

Authors:  E D Williams; C L Brown; I Doniach
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411

8.  Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study.

Authors:  Pauline Brindel; Françoise Doyon; Frédérique Rachédi; Jean-Louis Boissin; Joseph Sebbag; Larrys Shan; Vaiana Chungue; Laure Yen Kai Sun; Frédérique Bost-Bezeaud; Patrice Petitdidier; John Paoaafaite; Joseph Teuri; Florent de Vathaire
Journal:  Am J Epidemiol       Date:  2007-10-26       Impact factor: 4.897

9.  The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients.

Authors:  N A Samaan; P N Schultz; R C Hickey; H Goepfert; T P Haynie; D A Johnston; N G Ordonez
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

10.  Medullary thyroid carcinoma: targeted therapies and future directions.

Authors:  Scott N Pinchot; Muthusamy Kunnimalaiyaan; Rebecca S Sippel; Herbert Chen
Journal:  J Oncol       Date:  2009-12-24       Impact factor: 4.375

View more
  117 in total

1.  Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.

Authors:  Yu Sun; Tiefeng Shi; Yanfei Ma; Huadong Qin; Kang Li
Journal:  Cell Cycle       Date:  2020-02-20       Impact factor: 4.534

2.  Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.

Authors:  E Prokopakis; M Doulaptsi; A Kaprana; S Velegrakis; Y Vlastos; G Velegrakis
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

3.  The rare intracellular RET mutation p.S891A in a Chinese Han family with familial medullary thyroid carcinoma.

Authors:  Xiao-Ping Qi; Rong-Xin Zhang; Jin-Lin Cao; Zhen-Guang Chen; Hang-Yang Jin; Ren-Rong Yang
Journal:  J Biosci       Date:  2014-06       Impact factor: 1.826

Review 4.  Hurthle Cell Lesion: Controversies, Challenges, and Debates.

Authors:  Michael Shawky; Mahmoud Sakr
Journal:  Indian J Surg       Date:  2015-10-30       Impact factor: 0.656

5.  Parity and Risk of Thyroid Cancer: a Population-Based Study in Lithuania.

Authors:  L Zabuliene; D Jasilionis; E Miseikyte-Kaubriene; R Stukas; A Kaceniene; G Smailyte
Journal:  Horm Cancer       Date:  2017-09-15       Impact factor: 3.869

6.  Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.

Authors:  Sarah C Oltmann; Glen Leverson; Suzy Hsiu-I Lin; David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2013-12-18       Impact factor: 2.192

7.  Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.

Authors:  David F Schneider; Dawn Elfenbein; Ricardo V Lloyd; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-08-05       Impact factor: 5.344

8.  Identification of a novel HRAS variant and its association with papillary thyroid carcinoma.

Authors:  Rui Dou; Lili Zhang; Tingxia Lu; Dong Liu; Fang Mei; Jian Huang; Linxue Qian
Journal:  Oncol Lett       Date:  2018-01-17       Impact factor: 2.967

9.  Changing patterns in thyroid cancer incidence and mortality in the Slovak Republic by histological type and age.

Authors:  Martina Ondrusova; Karol Kajo; Dalibor Ondrus
Journal:  Int J Clin Oncol       Date:  2013-11-09       Impact factor: 3.402

10.  TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway.

Authors:  Xiaobo Xu; Hongqiang Gao; Jian Qin; Liu He; Wenyong Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.